Absci (ABSI) Operating Leases (2020 - 2026)

Absci (ABSI) reported Operating Leases of $2.1 million for Q1 2026, down 46.42% on a YoY basis from $4.0 million in Q1 2025, and down 18.25% sequentially from $2.6 million in Q4 2025.

Absci (ABSI) Operating Leases (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Operating Leases data on file, last reported at $2.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 46.42% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 46.42% YoY), and the FY2025 full-year result was $2.6 million, down 40.75% from the prior year.
  • Operating Leases fell to $2.1 million in Q1 2026, from $2.6 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $8.6 million in Q1 2022 to a low of $2.1 million in Q1 2026.
  • A 5-year average of $5.4 million and a median of $5.3 million in 2024 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases fell 16.17% in 2022 and sank 46.42% in 2026, its largest moves.
  • Tracing ABSI's Operating Leases over 5 years: stood at $7.3 million in 2022, then dropped by 22.88% to $5.6 million in 2023, then retreated by 21.51% to $4.4 million in 2024, then plunged by 40.75% to $2.6 million in 2025, then declined by 18.25% to $2.1 million in 2026.
  • Business Quant data shows ABSI's Operating Leases at $2.1 million in Q1 2026, $2.6 million in Q4 2025, and $3.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Absci 1.23 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.15 Mn
Dec 31, 2025 2.62 Mn
Sep 30, 2025 3.09 Mn
Jun 30, 2025 3.55 Mn
Mar 31, 2025 4.00 Mn
Dec 31, 2024 4.43 Mn
Sep 30, 2024 4.85 Mn
Jun 30, 2024 5.26 Mn
Mar 31, 2024 5.30 Mn
Dec 31, 2023 5.64 Mn
Sep 30, 2023 6.00 Mn
Jun 30, 2023 6.42 Mn
Mar 31, 2023 6.88 Mn
Dec 31, 2022 7.32 Mn
Sep 30, 2022 7.85 Mn
Jun 30, 2022 8.18 Mn
Mar 31, 2022 8.57 Mn
Dec 31, 2021 8.97 Mn
Sep 30, 2021 9.36 Mn
Jun 30, 2021 10.40 Mn